TAZ anticorps (C-Term)
Aperçu rapide pour TAZ anticorps (C-Term) (ABIN1804255)
Antigène
Voir toutes TAZ AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Marque
- IHC-plus™
-
Specificité
- Human TAZ
-
Purification
- Immunoaffinity purified
-
Immunogène
-
Synthetic peptide corresponding to a region within amino acids 226 and 292 of TAZ (SwissProt Q16635). Percent identity by BLAST analysis: Human (100%).
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Indications d'application
-
Approved: ELISA, IHC, IHC-P (10 μg/mL)
Usage: Antibody reactive against peptide, detects immunogen. -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7, 10 % Glycerol, 0.01 % Thimerosal
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot and freeze at -20°C. Avoid freeze-thaw cycles.
-
-
- TAZ (Tafazzin (TAZ))
-
Autre désignation
- TAZ
-
Sujet
-
Name/Gene ID: TAZ
Synonyms: TAZ, BTHS, EFE, Endocardial fibroelastosis 2, EFE2, LVNCX, Protein G4.5, Tafazzin, CMD3A, G4.5, TAZ1, XAP-2 -
ID gène
- 6901
-
UniProt
- Q16635
Antigène
-